Cargando…
Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429065/ https://www.ncbi.nlm.nih.gov/pubmed/37587442 http://dx.doi.org/10.1186/s12967-023-04410-1 |
| _version_ | 1785090622048174080 |
|---|---|
| author | Huang, Po-Lin Kan, Hung-Tsai Hsu, Ching-Hsuan Hsieh, Hsin-Ta Cheng, Wan-Chien Huang, Ren-Yeong You, Jhong-Jhe |
| author_facet | Huang, Po-Lin Kan, Hung-Tsai Hsu, Ching-Hsuan Hsieh, Hsin-Ta Cheng, Wan-Chien Huang, Ren-Yeong You, Jhong-Jhe |
| author_sort | Huang, Po-Lin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429065 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104290652023-08-17 Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity Huang, Po-Lin Kan, Hung-Tsai Hsu, Ching-Hsuan Hsieh, Hsin-Ta Cheng, Wan-Chien Huang, Ren-Yeong You, Jhong-Jhe J Transl Med Correction BioMed Central 2023-08-16 /pmc/articles/PMC10429065/ /pubmed/37587442 http://dx.doi.org/10.1186/s12967-023-04410-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Huang, Po-Lin Kan, Hung-Tsai Hsu, Ching-Hsuan Hsieh, Hsin-Ta Cheng, Wan-Chien Huang, Ren-Yeong You, Jhong-Jhe Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity |
| title | Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity |
| title_full | Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity |
| title_fullStr | Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity |
| title_full_unstemmed | Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity |
| title_short | Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity |
| title_sort | correction: a bispecific antibody ap203 targeting pd-l1 and cd137 exerts potent antitumor activity without toxicity |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429065/ https://www.ncbi.nlm.nih.gov/pubmed/37587442 http://dx.doi.org/10.1186/s12967-023-04410-1 |
| work_keys_str_mv | AT huangpolin correctionabispecificantibodyap203targetingpdl1andcd137exertspotentantitumoractivitywithouttoxicity AT kanhungtsai correctionabispecificantibodyap203targetingpdl1andcd137exertspotentantitumoractivitywithouttoxicity AT hsuchinghsuan correctionabispecificantibodyap203targetingpdl1andcd137exertspotentantitumoractivitywithouttoxicity AT hsiehhsinta correctionabispecificantibodyap203targetingpdl1andcd137exertspotentantitumoractivitywithouttoxicity AT chengwanchien correctionabispecificantibodyap203targetingpdl1andcd137exertspotentantitumoractivitywithouttoxicity AT huangrenyeong correctionabispecificantibodyap203targetingpdl1andcd137exertspotentantitumoractivitywithouttoxicity AT youjhongjhe correctionabispecificantibodyap203targetingpdl1andcd137exertspotentantitumoractivitywithouttoxicity |